CXCR2 and pancreatic neoplasm: In Kras-driven pancreatic cancer, loss of Tp53 stimulates the production of myeloid chemokines, including CXCR2/3 ligands, resulting in the recruitment of immunosuppressive CD11b+ myeloid cells (Blagih et al., 2020).